
For Gilead Sciences (GILD) at $113.04, options strategies offer attractive "YieldBoost" opportunities. Selling a $112.00 strike put for $2.78 could yield an annualized 21.05% if it expires worthless (57% probability), effectively lowering the acquisition cost to $109.22. Concurrently, a covered call strategy involving the sale of a $115.00 strike call for $3.35 projects a 4.70% total return if exercised by November 7th, or a 25.13% annualized premium return if the call expires worthless (52% probability).
Analysis of current options pricing for Gilead Sciences (GILD) reveals two distinct yield-enhancement strategies. For investors seeking to acquire the stock, selling the $112.00 strike put contract for a $2.78 premium offers an effective purchase price of $109.22, a discount to the current $113.04 market price. This strategy carries a 57% statistical probability of the option expiring worthless, which would translate to a 21.05% annualized return on the cash commitment. For existing shareholders, a covered call strategy using the $115.00 strike yields a $3.35 premium, providing a potential 25.13% annualized return if the option expires worthless (a 52% probability). If the stock is called away, the total return is capped at 4.70% by the November 7th expiration. Notably, the implied volatility on the call (36%) is significantly higher than both the put's implied volatility (28%) and the stock's trailing twelve-month historical volatility (28%), suggesting that premiums for upside calls are currently elevated relative to historical price movement and downside protection.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment